Physician profile
Kendrick Che
NPI 1326251844
$3,549.76
in general payments reported to CMS, 2019-2025
10 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $418 · 2021: $29.66 · 2022: $18.77 · 2023: $710 · 2024: $198 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704 · Travel and Lodging: $743 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.40 |
| Travel and Lodging | $743.46 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,950.51 | 2019-2025 | Overstitch Endoscopic Suturing System, Exalt Model D, General - Therapies |
| Erbe USA INC | $435.86 | 2019-2025 | Erbevio3 |
| Cook Medical LLC | $374.90 | 2019-2025 | Saeed, Echotip Insight |
| Olympus America INC. | $211.09 | 2023-2025 | Disposable Grasping Forceps, Endoclot Phs, Visiglide |
| Conmed Corporation | $171.01 | 2025 | Conmed Biliary |
| Csa Medical, INC | $146.35 | 2019 | |
| Janssen Biotech, INC. | $99.00 | 2023 | Tremfya, Stelara |
| Fujifilm Healthcare Americas Corporation | $90.24 | 2024-2025 | Fujifilm |
| Abbvie INC. | $48.43 | 2021-2022 | |
| Covidien LP | $22.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendrick Che listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.